Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design (Q38492034)

3 September 2017

Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design (English)

1 reference

3 September 2017

25

1 reference

3 September 2017

Atul Pathak

4

0 references

Gianfranco Parati

Gianfranco Parati

19

0 references

Luis Miguel Ruilope

Luis Ruilope

21

0 references

William Wijns

William Wijns

28

0 references

Stephan Windecker

26

Stephan Windecker

1 reference

3 September 2017

15

Sverre E Kjeldsen

1 reference

3 September 2017

27

Adam Witkowski

1 reference

3 September 2017

30

Roland E Schmieder

1 reference

3 September 2017

1

Felix Mahfoud

1 reference

3 September 2017

14

Michael Joner

1 reference

3 September 2017

13

Guido Grassi

1 reference

3 September 2017

Michael Böhm

2

1 reference

3 September 2017

Michel Azizi

3

1 reference

3 September 2017

Isabelle Durand Zaleski

5

1 reference

3 September 2017

Sebastian Ewen

6

1 reference

3 September 2017

Kostantinos Tsioufis

7

1 reference

3 September 2017

Bert Andersson

8

1 reference

3 September 2017

Peter J Blankestijn

9

1 reference

3 September 2017

Michel Burnier

10

1 reference

3 September 2017

Gilles Chatellier

11

1 reference

3 September 2017

Sameer Gafoor

12

1 reference

3 September 2017

Thomas Felix Lüscher

16

1 reference

3 September 2017

Melvin D Lobo

17

1 reference

3 September 2017

Chaim Lotan

18

1 reference

3 September 2017

Josep Redon

20

1 reference

3 September 2017

Isabella Sudano

22

1 reference

3 September 2017

Christian Ukena

23

1 reference

3 September 2017

Evert van Leeuwen

24

1 reference

3 September 2017

Thomas Zeller

29

1 reference

3 September 2017

18 May 2015

1 reference

3 September 2017

European Heart Journal

1 reference

3 September 2017

36

1 reference

3 September 2017

2219-2227

1 reference

3 September 2017

33

1 reference

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

3 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Apparent and true resistant hypertension: definition, prevalence and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Expert consensus document from the European Society of Cardiology on catheter-based renal denervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Updated ESH position paper on interventional therapy of resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Renal denervation for the treatment of cardiovascular high risk-hypertension or beyond?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

What the interventionalist should know about renal denervation in hypertensive patients: a position paper by the ESH WG on the interventional treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Physiology in perspective: The Wisdom of the Body. Neural control of the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Relationship between central sympathetic activity and stages of human hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Sympathetic nervous system moves toward center stage in cardiovascular medicine: from Thomas Willis to resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

The human sympathetic nervous system: its relevance in hypertension and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Blood pressure changes after renal denervation at 10 European expert centers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Renal denervation in moderate treatment-resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

A controlled trial of renal denervation for resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Design considerations for clinical trials of autonomic modulation therapies targeting hypertension and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Hypertension: How should data from SYMPLICITY HTN-3 be interpreted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Predictors of blood pressure response in the SYMPLICITY HTN-3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Renal nerve ablation after SYMPLICITY HTN-3: confused at the higher level?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Innervation patterns may limit response to endovascular renal denervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Catheter-based renal denervation: the black box procedure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Catheter-based radiorefrequency renal denervation lowers blood pressure in obese hypertensive dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Impaired cardiac baroreflex sensitivity predicts response to renal sympathetic denervation in patients with resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Blood pressure response to renal nerve stimulation in patients undergoing renal denervation: a feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Hypertension in aging patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Central pulse pressure predicts BP reduction after renal denervation in patients with treatment-resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

The changing face of sympathetic overactivity in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Renal denervation--implications for chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Sympathetic activation secondary to chronic kidney disease: therapeutic target for renal denervation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Renal denervation in moderate to severe CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Ambulatory blood-pressure monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Ambulatory blood pressure monitoring is ready to replace clinic blood pressure in the diagnosis of hypertension: con side of the argument

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Long-term risk of sustained hypertension in white-coat or masked hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Ambulatory blood pressure monitoring and organ damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Disproportional decrease in office blood pressure compared with 24-hour ambulatory blood pressure with antihypertensive treatment: dependency on pretreatment blood pressure levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Joint UK societies' 2014 consensus statement on renal denervation for resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Adherence and persistence with taking medication to control high blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Recent data on off-pump coronary artery bypass grafting: the CORONARY and GOPCABE trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Measuring, analyzing, and managing drug adherence in resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Electronic monitors of drug adherence: tools to make rational therapeutic decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Potential lifetime cost-effectiveness of catheter-based renal sympathetic denervation in patients with resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Pharmacoeconomic evaluation in the real world. Effectiveness versus efficacy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Implementation of a hypertension clinic using a streamlined treatment algorithm

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Lack of placebo effect on ambulatory blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

Reduced Effect of Percutaneous Renal Denervation on Blood Pressure in Patients With Isolated Systolic Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV192

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHV192

1 reference

3 September 2017

1 reference